Takeda Pharmaceutical Co., Ltd./ JP3463000004 /
2024-11-07 3:30:00 PM | Chg. -1.8400 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
26.7600USD | -6.43% | 119,689 Turnover: 7,599.8400 |
-Bid Size: - | -Ask Size: - | 43.47 bill.USD | - | - |
GlobeNewswire
2019-10-16
Global RNA-Targeted Small Molecules Study, 2019: A Landscape Analysis of Companies, Technologies, Ta...
GlobeNewswire
2019-07-10
Worldwide Proton Pump Inhibitors (PPIs) Markets to 2023 with AstraZeneca, Bayer, Johnson & Johnson S...
GlobeNewswire
2019-06-28
Global Pericarditis Drugs Market Research Report 2019-2023 - Key Players are AstraZeneca, Bayer, Joh...
GlobeNewswire
2019-06-18
White Oil: $2.71Bn World Market Insights & Outlook to 2025 with Sonneborn, Sinopec, Nynas, Royal Dut...
GlobeNewswire
2019-04-25
Integrin Alpha 4 Therapeutics Pipeline Report, H1 2019 - Review of 9 Companies, Drug Profiles & Feat...
GlobeNewswire
2019-04-08
World Primary Immune Deficiency (PID) Therapeutics Pipeline Report, H1 2019 Edition with Review of K...
GlobeNewswire
2019-01-31
Gastrointestinal Diseases Pipeline Review, 2018 - Which Companies are the Most Active within Each Pi...
GlobeNewswire
2019-01-21
Global Women's Health Drugs Market Report 2019-2024 Featuring AbbVie Allergan Bayer, GlaxoSmithKline...
GlobeNewswire
2018-12-17
The Global Market for Cell Separation & Characterization in Solid Tumors (2018-2023): Abbvie, AstraZ...
GlobeNewswire
2018-09-17
World Vaccines (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, P...
GlobeNewswire
2018-08-30
Mesoblast Reports Fourth Quarter and Full-Year 2018 Financial Results and Operational Highlights